HB
ELV icon

Homrich & Berg’s Elevance Health ELV Stock Holding History

Homrich & Berg’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2.33M Buy
6,254
+1,122
+22% +$426K 0.05% 138
2021
Q2 		$1.96M Buy
5,132
+702
+16% +$268K 0.05% 153
2021
Q1 		$1.59M Buy
4,430
+3,734
+536% +$1.2M 0.04% 162
2020
Q4 		$223K Sell
696
-103
-13% -$31.6K 0.01% 364
2020
Q3 		$215K Sell
799
-184
-19% -$49.5K 0.01% 310
2020
Q2 		$259K Sell
983
-36
-4% -$9.6K 0.01% 267
2020
Q1 		$231K Buy
1,019
+16
+2% +$4.36K 0.01% 267
2019
Q4 		$303K Buy
+1,003
New +$276K 0.01% 298
2019
Q3 		– Sell
-780
Closed -$220K – 346
2019
Q2 		$220K Sell
780
-80
-9% -$21.9K 0.01% 323
2019
Q1 		$247K Buy
860
+36
+4% +$10.4K 0.01% 289
2018
Q4 		$216K Sell
824
-55
-6% -$15.1K 0.01% 277
2018
Q3 		$241K Sell
879
-37
-4% -$9.61K 0.01% 290
2018
Q2 		$218K Buy
+916
New +$212K 0.02% 296
2017
Q4 		– Sell
-2,206
Closed -$419K – 347
2017
Q3 		$419K Buy
+2,206
New +$420K 0.03% 204
2016
Q2 		– Sell
-1,695
Closed -$236K – 266
2016
Q1 		$236K Buy
1,695
+107
+7% +$14.3K 0.02% 231
2015
Q4 		$221K Sell
1,588
-51
-3% -$7.03K 0.02% 237
2015
Q3 		$229K Buy
+1,639
New +$246K 0.02% 232

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Homrich & Berg's ELV Position: Q3 2021 in Review

Homrich & Berg increased its Elevance Health (ELV) stake by 22% in Q3 2021, buying an estimated $426K and bringing the position to 6,254 shares worth $2.33M. The position accounts for 0.05% of the portfolio, ranked #138.

Homrich & Berg first reported a position in ELV in Q3 2015 and has held it in 17 quarters since. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • Homrich & Berg held 6,254 shares of Elevance Health worth $2.33M as of Q3 2021.
  • Homrich & Berg bought 1,122 Elevance Health shares in Q3 2021, an estimated $426K.
  • Elevance Health made up 0.05% of Homrich & Berg's portfolio in Q3 2021, its #138 holding.
  • Homrich & Berg first reported a position in Elevance Health in Q3 2015 and has held it in 17 quarters since.
  • 1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.